India’s Relaxed Foreign-Investment Laws Signal Opportunity, But No Guarantees
This article was originally published in The Rose Sheet
Executive Summary
Recent changes to regulations governing India’s retail industry could have an impact on the personal-care sector, which is poised to grow 15% to 20% annually in the country.
You may also be interested in...
Indian Beauty Ideal Evolves Across Emerging Middle Class
[Editor’s note: Following up on our own coverage of the Indian beauty market, “The Rose Sheet” presents this exclusive analysis of the Indian beauty consumer from outside contributor Elle Morris of LPK Beauty.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.